HBI1 Antibody

What is HBI1 and why is it important in plant research?

HBI1 is a basic helix-loop-helix (bHLH) transcription factor that functions as a crucial node mediating the trade-off between growth and immunity in plants, particularly in Arabidopsis thaliana. It is activated posttranscriptionally by growth-promoting hormonal and environmental signals through the triple-HLH/bHLH cascade but is repressed transcriptionally by pathogen-associated molecular pattern (PAMP) signals . HBI1 simultaneously activates growth-related pathways while inhibiting immunity, making it a central regulator in plant development and defense responses . Understanding HBI1 is essential for researchers investigating plant growth regulation, stress responses, and plant-pathogen interactions.

What are the primary research applications for HBI1 antibodies?

HBI1 antibodies are primarily used in plant molecular biology for:

• Western blot analysis to detect HBI1 protein expression levels

• Co-immunoprecipitation (co-IP) to identify protein interaction partners

• Chromatin immunoprecipitation (ChIP) to map genome-wide DNA binding sites

• Immunohistochemistry to visualize subcellular localization

• Pull-down assays to confirm direct protein-protein interactions

These applications have been demonstrated in research studying interactions between cryptochrome 1 (CRY1) and HBI1, where antibodies against tagged versions of HBI1 were used for immunoprecipitation and western blot analysis .

How does HBI1 function at the molecular level?

HBI1 functions as a transcription activator for most of its target genes. ChIP-Seq and RNA-Seq analyses have revealed that HBI1 directly binds to and activates genes involved in cell growth, hormonal responses (particularly BR and GA), and chloroplast function . Conversely, it represses genes involved in defense responses, ROS production, and stress hormone pathways . At the molecular level, HBI1's DNA binding ability can be inhibited by IBH1 through direct protein-protein interaction, while PRE1 counteracts this inhibition by interacting with IBH1 . Additionally, HBI1 interacts with photoreceptors like CRY1 in a blue light-dependent manner, connecting light signaling with growth and defense pathways .

What controls should be included when performing immunoprecipitation with HBI1 antibodies?

When performing immunoprecipitation with HBI1 antibodies, researchers should include:

• Input control: 5-10% of the total protein extract before immunoprecipitation

• Non-specific antibody control: Same species IgG

• Negative control: HBI1 knockout or knockdown plant extracts

• Positive control: Extracts from HBI1-overexpressing plants

• Light condition controls: When studying light-dependent interactions, samples exposed to different light conditions (blue, red, far-red, darkness) should be compared

For tagged HBI1 proteins, additional controls include empty vector transfection controls and tag-only expression controls. These controls are critical for validating specificity and demonstrating true interactions versus background binding.

What is the optimal protocol for ChIP-Seq using HBI1 antibodies?

Based on published HBI1 ChIP-Seq studies, the following protocol is recommended:

• Crosslinking: Treat plant tissue with 1% formaldehyde

• Chromatin extraction: Isolate and sonicate chromatin to 200-500bp fragments

• Immunoprecipitation: Incubate chromatin with anti-HBI1 or anti-tag antibodies

• Washing and elution: Use stringent washes to reduce non-specific binding

• Reverse crosslinking and DNA purification

• Library preparation and sequencing

• Data analysis: Use statistical software like CisGenome and PRI-CAT for peak identification

Previous HBI1 ChIP-Seq identified 1103 high-confidence binding peaks corresponding to 1447 target genes. Most binding sites were found in promoter regions, with CACATG (hormone up at dawn element) being the most enriched cis-element .

How should protein-protein interactions involving HBI1 be experimentally verified?

To verify HBI1 protein interactions, a multi-method approach is recommended:

• Yeast two-hybrid screening: For initial identification of potential interactors, as used to identify CIB1 and its homologs as CRY1 N-terminus interacting proteins

• In vitro pull-down assays: Using purified recombinant proteins

  • Express MBP-HBI1 in E. coli and purify using affinity chromatography

  • Incubate with amylose-magnetic beads in TBST buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Triton X-100, 10% glycerol)

  • Add potential interacting proteins and analyze bound proteins by immunoblotting

• Co-immunoprecipitation (co-IP):

  • Express HBI1-Flag in planta alongside potential interactors

  • Homogenize tissue in TBST buffer with protease inhibitors

  • Immunoprecipitate using protein G magnetic beads with anti-Flag antibody

  • Analyze by western blot with appropriate antibodies

• Protein co-localization: Using fluorescently tagged proteins to visualize subcellular co-localization patterns

Research has demonstrated these approaches for confirming interactions between HBI1 and light-responsive proteins such as CRY1 .

How should RNA-Seq and ChIP-Seq data for HBI1 be integrated to identify direct functional targets?

To identify direct functional targets of HBI1, integrate RNA-Seq and ChIP-Seq data using the following approach:

• Perform RNA-Seq on HBI1 overexpression or knockdown lines to identify differentially expressed genes

• Compare with ChIP-Seq data to identify genes that are both bound by HBI1 and differentially expressed

• Classify target genes based on regulation pattern (activated vs. repressed)

• Perform Gene Ontology (GO) analysis using tools like agriGO v2.0 with TAIR10 as reference

Previous research integrated these approaches and found:

• 156 out of 600 (26%) HBI1-induced genes were direct HBI1 binding targets

• Only 21 out of 657 (3.2%) HBI1-repressed genes were direct targets

• This indicates HBI1 primarily functions as a transcriptional activator

GO analysis revealed that HBI1 directly activates genes involved in growth-promoting hormone responses (BR, GA), while repressing genes involved in defense, stress hormones, and ROS production .

How can I differentiate between direct and indirect effects of HBI1 on gene expression?

Differentiating direct from indirect HBI1 regulatory effects requires:

• Time-course experiments:

  • Use inducible HBI1 expression systems

  • Monitor gene expression changes at multiple time points

  • Early responsive genes are more likely direct targets

• Integration of multiple datasets:

  • Compare ChIP-Seq and RNA-Seq data

  • Genes bound by HBI1 and showing expression changes are likely direct targets

  • Genes showing expression changes without HBI1 binding are likely indirect targets

• Motif analysis:

  • Analyze promoters of differentially expressed genes for HBI1 binding motifs (CACATG)

  • Presence of binding motifs supports direct regulation

• Transcription inhibition experiments:

  • Use transcription inhibitors like cycloheximide

  • Genes still responding to HBI1 modulation under protein synthesis inhibition are direct targets

Previous research showed only 26% of HBI1-induced genes were direct targets, highlighting the extensive indirect regulatory network downstream of HBI1 .

What bioinformatic approaches are recommended for analyzing HBI1 target gene functions?

For comprehensive functional analysis of HBI1 target genes:

• Gene Ontology (GO) enrichment analysis:

  • Use agriGO v2.0 with TAIR10 as reference

  • Apply hypergeometric statistical test method

  • Analyze complete GO type for comprehensive functional categorization

• Pathway enrichment analysis:

  • Classify target genes into biological pathways

  • HBI1 targets are enriched in hormone signaling, stress response, and metabolism pathways

• Comparative transcriptome analysis:

  • Compare HBI1-regulated genes with those regulated by related transcription factors

  • HBI1 and PIFs co-regulate 720 genes, with 464 (64.4%) regulated in the same direction

• Cis-regulatory element analysis:

  • Identify enriched motifs in promoters of target genes

  • CACATG (hormone up at dawn element) is significantly enriched in HBI1 targets

• Venn diagram and heatmap visualization:

  • Use Venny (http://bioinfogp.cnb.csic.es/tools/venny/) for set comparisons

  • Generate heatmaps with hierarchical clustering using MeV 4.7 software

How can I investigate the competitive binding dynamics between HBI1 and other bHLH transcription factors?

To study competitive binding between HBI1 and other bHLH factors:

• Electrophoretic Mobility Shift Assay (EMSA):

  • Use purified recombinant HBI1 and competing bHLH proteins

  • Incubate with labeled DNA probes containing CACATG motifs

  • Analyze binding competition through shifts in migration patterns

• Sequential ChIP (re-ChIP):

  • First ChIP with antibody against HBI1

  • Second ChIP with antibody against competing factor

  • Quantify co-occupancy at genomic regions

• Modified pull-down assays:

  • Immobilize DNA containing HBI1 binding sites

  • Add mixtures of purified factors at varying ratios

  • Quantify bound proteins via western blot

• Competitive transcriptional assays:

  • Use reporter constructs with HBI1 binding elements

  • Co-express HBI1 with varying levels of competitors like IBH1

  • Measure transcriptional output

Research has shown that IBH1 interacts with HBI1 to inhibit its transcriptional activity by repressing DNA binding, which is counteracted by PRE1 through direct interaction with IBH1 , demonstrating the complex competitive dynamics that can be investigated with these approaches.

What techniques are optimal for studying light-dependent interactions between HBI1 and photoreceptors?

To investigate light-dependent interactions between HBI1 and photoreceptors such as CRY1:

• Light-condition-specific co-immunoprecipitation:

  • Grow plants under specific light conditions (blue, red, far-red) or darkness

  • Perform co-IP experiments to detect differential interactions

  • Research shows CRY1 interacts with HBI1 in a blue light-dependent manner

• In vivo pull-down assays with light-treated samples:

  • Grow CRY1-OX seedlings under white light, then dark-adapt

  • Transfer to specific light conditions (red, blue, far-red) or keep in darkness

  • Homogenize tissue and perform pull-down with MBP-HBI1-conjugated beads

  • Analyze precipitates by western blot with anti-Myc antibody

• Fluorescence resonance energy transfer (FRET):

  • Generate fluorescent protein fusions

  • Monitor interaction dynamics in real-time under changing light conditions

• Bimolecular fluorescence complementation (BiFC):

  • Express complementary fluorescent protein fragments fused to HBI1 and photoreceptors

  • Quantify reconstituted fluorescence under different light conditions

Previous research demonstrated that CRY1 interacts with HBI1 in a blue light-dependent manner, while this interaction was not observed under red light, far-red light, or in darkness .

What methods can be used to determine how HBI1 affects chromatin structure at target genes?

To investigate HBI1's effects on chromatin structure:

• ChIP-Seq for histone modifications:

  • Compare histone modification patterns (H3K4me3, H3K27ac, H3K9me2) at HBI1 target loci between wild-type and HBI1 overexpression/knockout lines

  • Correlate modifications with gene expression changes

• Assay for Transposase-Accessible Chromatin (ATAC-seq):

  • Compare chromatin accessibility in different HBI1 genetic backgrounds

  • Identify regions where HBI1 binding correlates with changes in accessibility

• DNase I hypersensitivity assays:

  • Map open chromatin regions in HBI1 variant backgrounds

  • Correlate with HBI1 binding sites from ChIP-Seq

• Chromosome conformation capture (3C/4C/Hi-C):

  • Investigate whether HBI1 affects chromatin looping or higher-order structure

  • Identify potential enhancer-promoter interactions mediated by HBI1

• ChIP for chromatin modifiers:

  • Determine if HBI1 recruits specific histone modifying enzymes to target genes

  • Perform sequential ChIP for HBI1 and chromatin modifiers

These approaches would complement existing knowledge that HBI1 regulates numerous genes involved in growth and defense pathways, providing mechanistic insight into how it modulates chromatin to control gene expression .

What are common challenges in HBI1 ChIP experiments and how can they be addressed?

Common challenges in HBI1 ChIP experiments include:

• Low signal-to-noise ratio:

  • Increase crosslinking efficiency by optimizing formaldehyde concentration (1-1.5%)

  • Improve sonication conditions for consistent chromatin fragmentation

  • Use tandem affinity purification tags for improved specificity

  • Increase stringency of wash buffers

• Antibody specificity concerns:

  • Validate antibody specificity using HBI1 overexpression and knockout lines

  • Use epitope-tagged HBI1 with commercial anti-tag antibodies

  • Pre-clear chromatin with protein A/G beads before immunoprecipitation

• Low HBI1 abundance:

  • Use inducible overexpression systems

  • Increase starting material

  • Optimize extraction buffers with appropriate protease inhibitors

  • Consider native ChIP approaches for factors with weak DNA interactions

• High background in control samples:

  • Include IgG controls and no-antibody controls

  • Use highly specific blocking agents

  • Perform sequential ChIP to improve specificity

Previous HBI1 ChIP-Seq studies successfully identified 1103 high-confidence binding peaks, demonstrating that these challenges can be overcome with proper optimization .

How can qRT-PCR be optimized for studying HBI1 target gene expression?

For optimal qRT-PCR analysis of HBI1 target genes:

• Sample preparation:

  • Use WT, cry1cry2, CRY1-OX, CRY2-OX, HBI1-EAR-OX/cry1cry2, and HBI1-OX seedlings

  • Standardize growth conditions (e.g., white light treatment for 12h to promote germination followed by 4d darkness before light exposure)

• RNA extraction and quality control:

  • Extract total RNA using optimized protocols (e.g., TIANGEN manufacturer instructions)

  • Verify RNA quality by spectrophotometry and gel electrophoresis

  • Treat with DNase to remove genomic DNA contamination

• Primer design considerations:

  • Design primers spanning exon-exon junctions to avoid genomic amplification

  • Optimize primer length (18-22bp) and Tm (58-62°C)

  • Validate primer efficiency using standard curves

  • Use multiple reference genes for normalization (PP2A recommended)

• Experimental controls:

  • Include no-template controls

  • Include no-reverse transcriptase controls

  • Use biological and technical replicates (minimum 3 each)

  • Include reference genes for normalization (PP2A has been validated)

• Data analysis:

  • Use the comparative Ct (2^-ΔΔCt) method

  • Normalize to validated reference genes

  • Apply appropriate statistical tests for significance

This approach has been successfully applied in previous studies analyzing HBI1-regulated gene expression under various light conditions .

How can CRISPR-Cas9 genome editing be used to study HBI1 function?

CRISPR-Cas9 technology offers powerful approaches for studying HBI1:

• Generation of precise HBI1 knockout lines:

  • Design sgRNAs targeting conserved HBI1 domains

  • Create knockouts to study loss-of-function phenotypes

  • Generate HBI1 mutant allelic series to study domain-specific functions

• Tagging endogenous HBI1:

  • Introduce epitope tags or fluorescent proteins at the native locus

  • Maintain endogenous regulation while enabling protein detection

  • Avoid artifacts associated with overexpression

• Base editing of specific regulatory elements:

  • Modify HBI1 binding sites in target gene promoters

  • Create point mutations in HBI1 to disrupt specific protein interactions

  • Investigate the importance of specific amino acids in HBI1 function

• CRISPRi/CRISPRa for modulating HBI1 expression:

  • Use dCas9-based approaches to repress or activate HBI1 in specific tissues

  • Create inducible systems for temporal control of HBI1 expression

  • Study dosage effects of HBI1 on growth-defense trade-offs

• Multiplexed editing:

  • Simultaneously target HBI1 and interacting partners (CRY1, IBH1, PRE1)

  • Create higher-order mutants to study genetic interactions

These approaches would extend current knowledge that HBI1 mediates the trade-off between growth and immunity in plants , providing more precise tools to dissect its molecular function.

What are emerging technologies for studying the dynamics of HBI1-DNA interactions?

Emerging technologies for studying HBI1-DNA interaction dynamics include:

• CUT&RUN and CUT&TAG:

  • Higher signal-to-noise ratio than traditional ChIP

  • Requires fewer cells and less starting material

  • Better for detecting weaker or transient interactions

• ChIP-exo and ChIP-nexus:

  • Provide higher resolution of protein binding sites

  • Can map HBI1 binding sites with near-nucleotide resolution

  • Better define borders of protected DNA regions

• Single-molecule imaging techniques:

  • Use fluorescently labeled HBI1 to track real-time DNA binding

  • Measure residence time and binding kinetics

  • Observe direct competition between HBI1 and other factors

• HiChIP and PLAC-seq:

  • Combine chromatin interaction mapping with HBI1 ChIP

  • Identify long-range interactions mediated by HBI1

  • Map 3D genome organization influenced by HBI1

• Cleavage Under Targets and Release Using Nuclease (CUT&RUN):

  • Improved specificity over traditional ChIP

  • Lower background signal

  • Requires fewer cells

These approaches would enhance our understanding of HBI1's role as a mediator of growth-immunity trade-offs by providing more detailed spatial and temporal information about its genomic interactions .

How will single-cell technologies advance our understanding of HBI1 function?

Single-cell technologies offer transformative approaches for studying HBI1:

• Single-cell RNA-seq (scRNA-seq):

  • Map HBI1-regulated gene expression at cellular resolution

  • Identify cell-type specific responses to HBI1 modulation

  • Discover previously unrecognized heterogeneity in HBI1 activity

• Single-cell ATAC-seq (scATAC-seq):

  • Measure chromatin accessibility changes mediated by HBI1 at single-cell level

  • Identify cell populations with differential HBI1 activity

  • Correlate with scRNA-seq for multi-omics integration

• Spatial transcriptomics:

  • Map HBI1 activity across plant tissues with spatial context

  • Correlate HBI1 function with tissue microenvironments

  • Identify spatial domains of HBI1-regulated gene expression

• CyTOF and single-cell proteomics:

  • Measure protein-level changes downstream of HBI1

  • Quantify post-translational modifications at single-cell resolution

  • Build signaling networks from HBI1 to cellular effectors

These technologies will advance our understanding of how HBI1 mediates growth-immunity trade-offs at tissue and cellular levels, revealing how this single transcription factor coordinates complex developmental and defense responses across different cell types .